Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emi Noguchi

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Cancer Chemotherapy and Pharmacology|May 26, 2017
Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancerMayu Yunokawa, Hiroshi Yoshida, Reiko Watanabe, et al.
Case Reports in Oncological Medicine|March 25, 2020
Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E MutationTakuji Seo, Emi Noguchi, Masayuki Yoshida, et al.
Oncology|June 12, 2020
Treatment Outcome of Second-Line Chemotherapy for Gynecologic CarcinosarcomaTakahiro Ebata, Kan Yonemori, Tadaaki Nishikawa, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2019
The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary SiteJun Sato, Tatsunori Shimoi, Akihiko Shimomura, et al.
The American Journal of Surgical Pathology|May 28, 2021
Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 CasesTakahiro Shibayama, Tatsunori Shimoi, Taisuke Mori, et al.
Clinical and Translational Science|December 31, 2020
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugsTomomi Hata, Kenichi Nakamura, Kan Yonemori, et al.
Investigational New Drugs|July 23, 2017
Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapySeiko Bun, Kan Yonemori, Toru Akagi, et al.
Breast Cancer (Tokyo, Japan)|February 10, 2019
Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese populationShoko Noda-Narita, Akihiko Shimomura, Asuka Kawachi, et al.
Internal Medicine (Tokyo, Japan)|September 26, 2017
Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total GastrectomySakura Iizumi, Tatsunori Shimoi, Tadaaki Nishikawa, et al.
BMC Cancer|December 6, 2017
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective studySakura Iizumi, Tatsunori Shimoi, Natsuko Tsushita, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Cancer Chemotherapy and Pharmacology|May 26, 2017
Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancerMayu Yunokawa, Hiroshi Yoshida, Reiko Watanabe, et al.
Case Reports in Oncological Medicine|March 25, 2020
Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E MutationTakuji Seo, Emi Noguchi, Masayuki Yoshida, et al.
Oncology|June 12, 2020
Treatment Outcome of Second-Line Chemotherapy for Gynecologic CarcinosarcomaTakahiro Ebata, Kan Yonemori, Tadaaki Nishikawa, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2019
The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary SiteJun Sato, Tatsunori Shimoi, Akihiko Shimomura, et al.
The American Journal of Surgical Pathology|May 28, 2021
Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 CasesTakahiro Shibayama, Tatsunori Shimoi, Taisuke Mori, et al.
Clinical and Translational Science|December 31, 2020
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugsTomomi Hata, Kenichi Nakamura, Kan Yonemori, et al.
Investigational New Drugs|July 23, 2017
Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapySeiko Bun, Kan Yonemori, Toru Akagi, et al.
Breast Cancer (Tokyo, Japan)|February 10, 2019
Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese populationShoko Noda-Narita, Akihiko Shimomura, Asuka Kawachi, et al.
Internal Medicine (Tokyo, Japan)|September 26, 2017
Prolonged Hypocalcemia Following a Single Dose of Denosumab for Diffuse Bone Metastasis of Gastric Cancer after Total GastrectomySakura Iizumi, Tatsunori Shimoi, Tadaaki Nishikawa, et al.
BMC Cancer|December 6, 2017
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective studySakura Iizumi, Tatsunori Shimoi, Natsuko Tsushita, et al.
Pageof 6